Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Low-Intermediate Risk Prostate Cancer”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableLooking for participantsNCT03650595
What this trial is testing

MRI Guided Focal Laser Ablation of Prostate Cancer

Who this might be right for
Prostate CancerLow and Intermediate Risk Prostate Cancer
University Health Network, Toronto 102
Early research (Phase 1)Study completedNCT02390063
What this trial is testing

Vaccination in Prostate Cancer (VANCE)

Who this might be right for
Prostate Cancer
University of Oxford 40
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)WithdrawnNCT04243941
What this trial is testing

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03815942
What this trial is testing

VAccination in Early and ADvanced Prostate caNCEr

Who this might be right for
Intermediate Risk Prostate CancerCastration-resistant Prostate Cancer
University of Oxford 23
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Not applicableLooking for participantsNCT03830788
What this trial is testing

Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy

Who this might be right for
Prostate Cancer
Center Eugene Marquis 240
Not applicableLooking for participantsNCT07130682
What this trial is testing

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Who this might be right for
Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital 35
Testing effectiveness (Phase 2)UnknownNCT02643511
What this trial is testing

Hemiablative Focal Brachytherapy Pilot Study

Who this might be right for
Prostate Cancer
St George Hospital, Australia 20
Not applicableStudy completedNCT02600156
What this trial is testing

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Who this might be right for
Prostate CancerProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
Mayo Clinic 7
Not applicableLooking for participantsNCT05438563
What this trial is testing

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Who this might be right for
Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8
Mayo Clinic 100
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07644598
What this trial is testing

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Georgetown University 58
Not applicableUnknownNCT05584787
What this trial is testing

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

Who this might be right for
Prostate Cancer
San Carlo di Nancy Hospital 20
Not applicableStudy completedNCT01226576
What this trial is testing

Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study

Who this might be right for
Localized Low-Intermediate Risk Prostate Cancer
InSightec 8
Not applicableLooking for participantsNCT06117059
What this trial is testing

The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance

Who this might be right for
Localized Prostate CancerLow Risk Prostate CancerIntermediate Risk Prostate Cancer
NHS Lothian 100
Large-scale testing (Phase 3)Study completedNCT04627896
What this trial is testing

Targeted Microwave Focal Therapy

Who this might be right for
Prostate Cancer Stage I
A.O.U. Città della Salute e della Scienza 11
Testing effectiveness (Phase 2)Looking for participantsNCT06461819
What this trial is testing

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)

Who this might be right for
Low-to-intermediate-risk Prostate Carcinoma
Samsung Medical Center 33
Next Page